Next Science Limited (ASX:NXS)

Next Science Statistics

Total Valuation

Next Science has a market cap or net worth of AUD 42.43 million. The enterprise value is 49.04 million.

Market Cap	42.43M
Enterprise Value	49.04M

Important Dates

The next estimated earnings date is Thursday, October 23, 2025.

Earnings Date	Oct 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Next Science has 292.63 million shares outstanding. The number of shares has increased by 24.69% in one year.

Current Share Class	292.63M
Shares Outstanding	292.63M
Shares Change (YoY)	+24.69%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	31.33%
Owned by Institutions (%)	7.05%
Float	139.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.26
PB Ratio	-49.94
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.41
EV / Sales	1.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.60

Financial Position

The company has a current ratio of 1.38

Current Ratio	1.38
Quick Ratio	1.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.92
Interest Coverage	-12.63

Financial Efficiency

Return on equity (ROE) is -289.70% and return on invested capital (ROIC) is -85.88%.

Return on Equity (ROE)	-289.70%
Return on Assets (ROA)	-50.99%
Return on Invested Capital (ROIC)	-85.88%
Return on Capital Employed (ROCE)	-187.76%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	2.07
Inventory Turnover	5.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.50% in the last 52 weeks. The beta is 1.11, so Next Science's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	-27.50%
50-Day Moving Average	0.14
200-Day Moving Average	0.11
Relative Strength Index (RSI)	56.34
Average Volume (20 Days)	169,710

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Next Science had revenue of AUD 33.66 million and -14.39 million in losses. Loss per share was -0.05.

Revenue	33.66M
Gross Profit	27.76M
Operating Income	-13.24M
Pretax Income	-14.39M
Net Income	-14.39M
EBITDA	-12.52M
EBIT	-13.24M
Loss Per Share	-0.05

Balance Sheet

The company has 1.48 million in cash and 8.09 million in debt, giving a net cash position of -6.61 million or -0.02 per share.

Cash & Cash Equivalents	1.48M
Total Debt	8.09M
Net Cash	-6.61M
Net Cash Per Share	-0.02
Equity (Book Value)	-849,644
Book Value Per Share	-0.00
Working Capital	2.78M

Cash Flow

In the last 12 months, operating cash flow was -8.71 million and capital expenditures -52,890, giving a free cash flow of -8.76 million.

Operating Cash Flow	-8.71M
Capital Expenditures	-52,890
Free Cash Flow	-8.76M
FCF Per Share	-0.03

Margins

Gross margin is 82.48%, with operating and profit margins of -39.35% and -42.74%.

Gross Margin	82.48%
Operating Margin	-39.35%
Pretax Margin	-42.74%
Profit Margin	-42.74%
EBITDA Margin	-37.20%
EBIT Margin	-39.35%
FCF Margin	n/a

Dividends & Yields

Next Science does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.69%
Shareholder Yield	n/a
Earnings Yield	-33.90%
FCF Yield	-20.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3